{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:04:49Z","timestamp":1784804689269,"version":"3.55.0"},"reference-count":29,"publisher":"Rambam Health Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"DOI":"10.5041\/rmmj.10278","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T04:02:24Z","timestamp":1485748944000},"page":"e0003","source":"Crossref","is-referenced-by-count":1,"title":["Juvenile Idiopathic Arthritis in the Era of International Cooperation"],"prefix":"10.5041","volume":"8","author":[{"given":"Yosef","family":"Uziel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2983","published-online":{"date-parts":[[2017,1,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","unstructured":"1. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet 2011;377:2138-49.","journal-title":"Lancet"},{"key":"ref1","unstructured":"2. Consolaro A, Negro G, Lanni S, Solari N, Martini A, Ravelli A. Toward a treat-to-target approach in the management of juvenile idiopathic arthritis. Clin Exp Rheumatol 2012;30(4 Suppl 73):S157-62."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","unstructured":"3. Ruperto N, Lovell DJ, Cuttica R, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2007; 56:3096-106.","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/ard.2009.100354","article-title":"Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: findings from an open-label treatment extension","volume":"69","author":"Ruperto","year":"2010","unstructured":"4. Ruperto N, Lovell DJ, Cuttica R, et al. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Ann Rheum Dis 2010;69:718-22.","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","unstructured":"5. Lovell DJ, Ruperto N, Goodman S, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008;359:810-20.","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","unstructured":"6. Ruperto N, Daniel J, Lovell DJ, et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008;372:383-91.","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","unstructured":"7. Ruperto N, Brunner HI, Quartier P, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2396-406.","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","unstructured":"8. De Benedetti F, Brunner HI, Ruperto N, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2385-95.","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","article-title":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative initiative","volume":"75","author":"Ravelli","year":"2016","unstructured":"9. Ravelli A, Minoia F, Dav\u00ec S, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative initiative. Ann Rheum Dis 2016;75:481-9.","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","unstructured":"10. Minoia F, Dav\u00ec S, Horne A, et al. Clinical features, treatment and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 2014;66:3160-9.","journal-title":"Arthritis Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/art.39407","article-title":"Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab","volume":"68","author":"Grom","year":"2016","unstructured":"11. Grom AA, Ilowite NT, Pascual V, et al. Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab. Arthritis Rheum 2016;68:218-28.","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative initiative","volume":"68","author":"Ravelli","year":"2016","unstructured":"12. Ravelli A, Minoia F, Dav\u00ec S, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative initiative. Arthritis Rheumatol 2016;68:566-76.","journal-title":"Arthritis Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.bor.0000130286.54383.ea","article-title":"International research networks in pediatric rheumatology: the PRINTO perspective","volume":"16","author":"Ruperto","year":"2004","unstructured":"13. Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004;16:566-70.","journal-title":"Curr Opin Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1546-0096-11-5","article-title":"Time to SHARE","volume":"11","author":"NM","year":"2013","unstructured":"14. Wulffraat NM, Vastert B. Time to SHARE. Pediatric Rheumatol Online J 2013;11:5.","journal-title":"Pediatric Rheumatol Online J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMe1212640","article-title":"A new era in the treatment of systemic juvenile idiopathic arthritis","volume":"367","author":"Sandborg","year":"2012","unstructured":"15. Sandborg C, Mellins ED. A new era in the treatment of systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2439-40.","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Ravelli A, Minoia F, Dav\u00ec S, et al. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open 2016;2:e000161.","DOI":"10.1136\/rmdopen-2015-000161"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","unstructured":"17. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342:763-9.","journal-title":"N Engl J Med"},{"key":"ref17","unstructured":"18. Hashkes P, Uziel Y, Press J, et al. The Hebrew version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire. Clin Exp Rheumatol 2001;19(Suppl 23):S86-90."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12969-016-0085-5","article-title":"Clinical outcome measures in juvenile idiopathic arthritis","volume":"14","author":"Consolaro","year":"2016","unstructured":"19. Consolaro A, Giancane G, Schiappapietra B, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2016;14:23.","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1136\/annrheumdis-2013-204186","article-title":"Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score","volume":"73","author":"Consolaro","year":"2014","unstructured":"20. Consolaro A, Ruperto N, Bracciolini G, et al. Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score. Ann Rheum Dis 2014;73:1380-3.","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees","volume":"63","author":"Dougados","year":"2004","unstructured":"21. Dougados M, Betteridge N, Burmester GR, et al. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 2004; 63:1172-6.","journal-title":"Ann Rheum Dis"},{"key":"ref21","unstructured":"22. Vastert SJ, Boom V, Anton J, et al. Evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis. Arthritis Rheum 2014; 66;11:S120."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1136\/ard.2004.030221","article-title":"it","volume":"64","author":"Ruperto","year":"2005","unstructured":"23. Ruperto N, Garcia-Munitis P, Villa L, et al. PRINTO\/ PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it. Ann Rheum Dis 2005;64:1101-6.","journal-title":"Ann Rheum Dis"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Mendelson A, Rabinowicz N, Reis Y, et al. Comic book as an educational tool for children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2017 (abstract, forthcoming).","DOI":"10.1186\/s12969-017-0198-5"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Altavilla A, Manfredi C, Baiardi P, et al. Impact of the new European paediatric regulatory framework on ethics committees: overview and perspectives. Acta Paediatr 2012;101:e27-32.","DOI":"10.1111\/j.1651-2227.2011.02401.x"},{"key":"ref25","unstructured":"26. Hashkes PJ, Uziel Y, Rubenstein M, et al. The Israeli internet-based registry: novel concept of multicenter data collection in pediatric rheumatology experience. Pediatr Rheumatol Online J 2004;2:37-50."},{"key":"ref26","unstructured":"27. Uziel Y, Pomeranz A, Brik R, et al. Seasonal variation in systemic onset juvenile rheumatoid arthritis in Israel. J Rheumatol 1999;26:1187-9."},{"key":"ref27","unstructured":"28. Harel L, Prais D, Uziel Y, et al. Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis. J Rheumatol 2006;33:164-6."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-6-1","article-title":"Nitrous oxide sedation for intra-articular injections in juvenile idiopathic arthritis","volume":"6","author":"Uziel","year":"2008","unstructured":"29. Uziel Y, Chapnik G, Rothchild M, et al. Nitrous oxide sedation for intra-articular injections in juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2008;6:1","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/618\/1\/PublishFiles\/651Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:35:58Z","timestamp":1784802958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/32\/Articles\/651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,30]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10278","relation":{},"ISSN":["2076-9172"],"issn-type":[{"value":"2076-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,30]]}}}